Leticia Fernández
- Oncology top 10%
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 7
- Peptidase Inhibition and Analysis 3
- Global Cancer Incidence and Screening 3
- Immunology top 10%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 5
- Immune cells in cancer 4
- Otorhinolaryngology top 10%
-
- Childhood Cancer Survivors' Quality of Life 2
Leticia Fernández
34 papers receiving 596 citations
Peers
Comparison fields: 5 of 88
- Oncology 376
- Immunology 240
- Otorhinolaryngology 24
- Pulmonary and Respiratory Medicine 96
- Pathology and Forensic Medicine 44
Countries citing papers authored by Leticia Fernández
This map shows the geographic impact of Leticia Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Fernández more than expected).
Fields of papers citing papers by Leticia Fernández
This network shows the impact of papers produced by Leticia Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Fernández. The network helps show where Leticia Fernández may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leticia Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 11 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 71 | |
| 12 | 2021 | 20 | |
| 13 | 2019 | 5 | |
| 14 | 2014 | 2 | |
| 15 | 2011 | 44 | |
| 16 | 2010 | 3 | |
| 17 | 2009 | 19 | |
| 18 | Incidence of and mortality from cancer in the Cuban woman in the 2000-2002 period | 2007 | 1 |
| 19 | Incidencia y mortalidad por cáncer en la mujer cubana: Trienio 2000-2002 | 2007 | 7 |
| 20 | 1998 | 11 |
About Leticia Fernández
Leticia Fernández is a scholar working on Oncology, Immunology and Health Information Management, having authored 35 papers that have together received 613 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (5 papers), Immune cells in cancer (4 papers), Peptidase Inhibition and Analysis (3 papers), Global Cancer Incidence and Screening (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Oncology (376 citations), Immunology (240 citations) and Otorhinolaryngology (24 citations). Leticia Fernández has collaborated with scholars based in Spain, Cuba and Argentina. Frequent co-authors include Hugo Arasanz, Grazyna Kochan, David Escors, Ester Blanco, Ana Bocanegra, Luisa Chocarro, Maider Garnica, Miriam Echaide, Pablo Ramos and Ruth Vera. Their work appears in journals such as International Journal of Molecular Sciences, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.